Mahgoub assumed his current role in 2021. Ibnsina Pharma distributes pharmaceutical products from over 350 Egyptian and multinational pharmaceutical companies to more than 50,000 customers, including pharmacies, hospitals, retail outlets, and wholesalers, with a fleet of around 850 vehicles. It recorded $465 million in revenues in the first half of 2024 with its market share reaching 29.2%. Mahgoub is also the chairman of the Arab International Investment Group and a board member of Faisal Islamic Bank of Egypt and Dar El Eyoun Hospital.